drugset / Trial / NCT03879707

Improving Sleep Quality After Total Joint Arthroplasty ( TJA)

NCT03879707

Phase 0 Withdrawn Stanford University
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is the evaluate and improve sleep quality after Total joint replacement.

Timeline

Start
2025-06
Primary completion
2028-06
Completion
2028-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 500 mg Oral
Subject Melatonin Small molecule 5 mg

Indications

No indication recorded.